- Home
- ALEC vs VALU Comparison
ALEC vs VALU Comparison
Compare ALEC & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- VALU
- Stock Information
- Founded
- ALEC 2013
- VALU 1931
- Country
- ALEC United States
- VALU United States
- Employees
- ALEC N/A
- VALU N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- VALU Investment Managers
- Sector
- ALEC Health Care
- VALU Finance
- Exchange
- ALEC Nasdaq
- VALU Nasdaq
- Market Cap
- ALEC 454.5M
- VALU 530.8M
- IPO Year
- ALEC 2019
- VALU N/A
- Fundamental
- Price
- ALEC $3.76
- VALU $51.32
- Analyst Decision
- ALEC Strong Buy
- VALU
- Analyst Count
- ALEC 5
- VALU 0
- Target Price
- ALEC $20.67
- VALU N/A
- AVG Volume (30 Days)
- ALEC 749.0K
- VALU 12.3K
- Earning Date
- ALEC 11-06-2024
- VALU 12-13-2024
- Dividend Yield
- ALEC N/A
- VALU 2.34%
- EPS Growth
- ALEC N/A
- VALU 8.76
- EPS
- ALEC N/A
- VALU 2.13
- Revenue
- ALEC $61,508,000.00
- VALU $36,628,000.00
- Revenue This Year
- ALEC N/A
- VALU N/A
- Revenue Next Year
- ALEC $118.87
- VALU N/A
- P/E Ratio
- ALEC N/A
- VALU $23.96
- Revenue Growth
- ALEC N/A
- VALU N/A
- 52 Week Low
- ALEC $3.49
- VALU $36.00
- 52 Week High
- ALEC $8.90
- VALU $58.45
- Technical
- Relative Strength Index (RSI)
- ALEC 35.09
- VALU 51.21
- Support Level
- ALEC $3.57
- VALU $48.93
- Resistance Level
- ALEC $6.14
- VALU $57.68
- Average True Range (ATR)
- ALEC 0.48
- VALU 2.00
- MACD
- ALEC -0.20
- VALU -0.31
- Stochastic Oscillator
- ALEC 10.19
- VALU 30.19
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under well-known brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and The Most Trusted Name in Investment Research. Its only operating segment being Publishing.